Companies ›Healthcare ›VHL.AX

VHL.AX — ASX Advanced Medical Equipment & Technology

Vitasora Health Ltd

A$0,01

Open in Charts → Attach watcher ⌖

— —

AUD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

19,4M AUD

P/E

—

EV / Rev

—

Div yield

—

Op margin

—

ROE

—

Net margin

—

Debt / equity

—

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

Vitasora Health Ltd operates in the healthcare sector, focusing on advanced medical equipment and technology, and generates revenue primarily through the development and provision of these medical technologies.

Business. Vitasora Health Ltd (VHL.AX) is an Australian healthcare company operating in the Advanced Medical Equipment & Technology industry. The firm is primarily listed on the Australian Securities Exchange (ASX). Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a provider of advanced medical equipment and technology.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryAdvanced Medical Equipment & Technology

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability

—

not yet wired

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning VHL.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to VHL.AX. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Vitasora Health Ltd (VHL.AX) is an Australian healthcare company operating in the Advanced Medical Equipment & Technology industry. The firm is primarily listed on the Australian Securities Exchange (ASX). Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a provider of advanced medical equipment and technology.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryAdvanced Medical Equipment & Technology

AI synthesis

GENERATED

Vitasora Health Ltd has a market capitalization of approximately 19.4 million AUD, with a market price of 0.01 AUD per share, indicating a very low valuation in the market. The company has a total of 1,939,627,201 basic and diluted shares outstanding, suggesting a potentially diluted ownership structure. However, the liquidity risk for the company could not be assessed due to the lack of balance-sheet inputs and no going-concern language in the source documents.

In terms of profitability, Vitasora Health Ltd reported a negative earnings per share (EPS) of -0.01 AUD, indicating a loss per share, and a revenue of 662,100.00 AUD, which is relatively low for a company in the advanced medical equipment and technology industry. These figures suggest that the company is not currently generating significant profits and may be in a growth or development phase.

The company's revenue is not segmented by geographic regions or business segments in the available data, making it difficult to assess the geographic exposure or the contribution of different business lines to the overall revenue. This lack of segmentation could be a concern for investors looking to understand the diversification of the company's revenue streams.

Looking at the growth trajectory, Vitasora Health Ltd has not provided specific numeric deltas for the current or next fiscal year, which makes it challenging to assess the company's growth expectations. The low revenue and negative EPS suggest that the company may be in an early stage of development or facing operational challenges.

The risk assessment for Vitasora Health Ltd indicates a low dilution risk, which is a positive sign for shareholders. However, the liquidity risk remains unassessed, which could be a red flag for potential investors. The company's financial health and future prospects are closely tied to its ability to generate positive cash flows and improve its profitability.

Recent events and filings for Vitasora Health Ltd do not provide detailed information on specific events or filings that could impact the company's operations or financial status. The lack of detailed information may indicate that the company is not currently a major player in the industry or that it is not disclosing significant events to the public.

Key takeaways

Vitasora Health Ltd has a low market valuation with a market price of 0.01 AUD per share and a market capitalization of 19.4 million AUD.
The company reported a negative EPS of -0.01 AUD and a revenue of 662,100.00 AUD, indicating a loss and low revenue generation.
The liquidity risk for the company could not be assessed due to the lack of balance-sheet inputs and no going-concern language in the source documents.
The company's revenue is not segmented by geographic regions or business segments, making it difficult to assess the diversification of the revenue streams.
The risk assessment indicates a low dilution risk, which is a positive sign for shareholders, but the liquidity risk remains unassessed.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Annual

ANNUALFiled 2023-08-31

FY 2023 · Full-year highlights

Revenue A$3.7M, +256,8% YoY; Operating income −43,2% YoY.

RevenueA$3.7M+256,8 % YoY

Operating income-A$10.1M−43,2 % YoY

Net income-A$10.1M−41,7 % YoY

Free cash flow-A$10.0M−42,3 % YoY

EPS—

Operating cash flow-A$9.2M−38,0 % YoY

Financials

Income statement

RevenueA$3.7M

Gross profitA$3.7M

Operating income-A$10.1M

Net income-A$10.1M

Margins

Gross margin99.2%

Operating margin-272.7%

Net margin-272.7%

FCF margin-271.1%

Balance sheet

Total assetsA$18.4M

Total liabilitiesA$3.7M

Total equityA$14.7M

Cash & equivalentsA$394.2k

Long-term debtA$57.4k

Cash flow

Operating cash flow-A$9.2M

CapEx—

Free cash flow-A$10.0M

SBC—

P&L flow · revenue → net income

Highlights

▍Revenue A$3.7M, +256,8% YoY
▍Operating income −43,2% YoY
▍Net income −41,7% YoY
▍Free cash flow −42,3% YoY
▍Net margin -272.7%

Valuation FY

Market price

A$0,01

Market cap

A$19.4M

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

—

Net cashⓘ

—

Current ratioⓘ

—

Debt / equityⓘ

—

ROAⓘ

—

ROEⓘ

—

Cash conversionⓘ

—

CapEx / revenueⓘ

—

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskUnknown

Benchmarks vs cohort

No cohort benchmark data available for this issuer yet.

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Market Price
input from market-data provider (delayed close or quote-shim mid)
Market Cap
market_price * shares_outstanding_diluted

Source documents

Vitasora Health Ltd Market data — financials · 2026-05-29
Vitasora Health Ltd Market data — analyst estimates · 2026-05-29

Ownership & reference

Leadership

Nicholas SmedleyExecutive Chairman of the Board

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

VHL.AXCanonical

ASX · AUD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskUnknown

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

2023-08-31 11:37 UTCEARNINGSAnnual results — FY 2023 Revenue AUD 3.7M · Net AUD -10.1M

The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation FY

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Leadership

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread